![Willard Dere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Willard Dere
Président chez
METAGENOMI THERAPEUTICS, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Dr. Willard H.
Dere, MD, is a Chief Medical Officer at Angitia Biopharmaceuticals Guangzhou Ltd., a Chairman at Metagenomi Therapeutics, Inc., an Independent Director at Seres Therapeutics, Inc. and an Independent Director at BioMarin Pharmaceutical, Inc. He is on the Board of Directors at Seres Therapeutics, Inc., BioMarin Pharmaceutical, Inc. and Peel Therapeutics, Inc. Dr. Dere was previously employed as an Independent Director by Mersana Therapeutics, Inc., an Independent Director by OCERA Therapeutics LLC, an Independent Director by Radius Health, Inc., a Professor-Emeritus by The University of Utah Health Sciences Center, an International Chief Medical Officer by Amgen, Inc., a Vice President-Endocrine & Bone by Eli Lilly & Co., and an Associate Professor by The Indiana University School of Medicine.
He also served on the board at Metagenomi Technologies LLC, Clinical & Translational Science Institute and Center for Genomic Medicine Massachusetts General Hospital.
He received his undergraduate degree from the University of California, Davis and a doctorate degree from the University of California, Davis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/06/2026 | 46 440 ( 0,02 % ) | 3 M $ | 31/05/2026 | |
| 09/06/2026 | 51 275 ( 0,14 % ) | 69 734 $ | 31/05/2026 | |
SERES THERAPEUTICS INC 0,02 % | 13/04/2026 | 1 587 ( 0,02 % ) | 11 617 $ | 31/05/2026 |
| 06/01/2026 | 0 ( -.--% ) | - $ | 31/12/2025 |
Postes actifs de Willard Dere
| Sociétés | Poste | Début |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 18/07/2016 |
| SERES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/07/2017 |
| METAGENOMI THERAPEUTICS, INC. | Président | 11/11/2025 |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Directeur Technique/Scientifique/R&D | 01/06/2023 |
Anciens postes connus de Willard Dere
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur/Membre du Conseil | 06/01/2026 |
| RADIUS HEALTH, INC. | Directeur/Membre du Conseil | 15/08/2022 |
| OCERA THERAPEUTICS INC | Directeur/Membre du Conseil | 11/12/2017 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/10/2014 |
| ░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Willard Dere
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Indiana University School of Medicine
 The Indiana University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Utah Health Sciences Center | |
Clinical & Translational Science Institute
 Clinical & Translational Science Institute Engineering & ConstructionIndustrial Services Provides infrastructure services | Industrial Services |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Angitia Biopharmaceuticals Guangzhou Ltd.
Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Center for Genomic Medicine Massachusetts General Hospital |
